MEMANTINA GRINDEKS 10mg tablets medication leaflet

N06DX01 memantine • Nervous system | Anti-dementia drugs | Other anti-dementia drugs

Memantine is a medication used to treat moderate to severe dementia associated with Alzheimer’s disease. It works by blocking NMDA (N-methyl-D-aspartate) receptors in the brain, reducing the excessive effects of glutamate, a neurotransmitter that, in high amounts, can contribute to nerve cell damage.

Memantine helps improve cognitive function, memory, and the ability to perform daily activities, but it does not cure Alzheimer’s disease. It is usually administered in tablet or oral solution form, with the dose gradually adjusted to minimize side effects.

Side effects may include dizziness, headaches, constipation, drowsiness, or confusion. In rare cases, hallucinations or high blood pressure may occur. It is important to take the medication as prescribed by a doctor, with regular monitoring of the patient’s condition.

General data about MEMANTINA GRINDEKS 10mg

Substance: memantine

Date of last drug list: 01-06-2025

Commercial code: W67741008

Concentration: 10mg

Pharmaceutical form: tablets

Quantity: 56

Product type: generic

Price: 69.42 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: AS GRINDEKS - LETONIA

Holder: AS GRINDEKS - LETONIA

Number: 13730/2021/08

Shelf life: 2 years

Concentrations available for memantine

10mg, 10mg/g, 10mg/ml, 15mg, 20mg, 5mg, 5mg/10mg/15mg/20mg, 5mg/dose, 5mg/dose eliberata

Other substances similar to memantine

Compensation lists for MEMANTINA GRINDEKS 10mg AS GRINDEKS

G16 (C1) - Dementia (degenerative, vascular, mixed)

Price

Copayment

Patient

69.42 RON

33.05 RON

36.37 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

69.42 RON

33.05 RON

36.37 RON